Lingnau Lutz 4
4 · NEKTAR THERAPEUTICS · Filed Jul 18, 2017
Insider Transaction Report
Form 4
Lingnau Lutz
Director
Transactions
- Exercise/Conversion
Common Stock
2017-07-14$14.26/sh+30,000$427,800→ 53,450 total - Exercise/Conversion
Stock Option
2017-07-14−30,000→ 0 totalExercise: $14.26From: 2011-09-30Exp: 2018-09-13→ Common Stock (30,000 underlying) - Sale
Common Stock
2017-07-14$20.76/sh−30,000$622,800→ 23,450 total
Footnotes (2)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $20.40 to $20.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.